Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Akanda Corp. (AKAN) vs Sunshine Biopharma, Inc. (SBFM)

Akanda Corp. and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. Sunshine Biopharma, Inc. is the larger, with a market value of $3.3M against $2.4M — 1.3× the size. Across the 10 metrics below, Akanda Corp. leads on 7 and Sunshine Biopharma, Inc. on 3.

Valuation

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S n/m 0.03 2.25
P/B n/m 0.04 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 2.48 12.29
EV/Sales n/m (0.34) 2.56
Earnings yield — (1,208.33%) (2.99%)
Free cash flow yield 0.00% (482.76%) 0.00%

Profitability

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Gross margin — 30.30% 53.94%
Operating margin — (16.65%) 0.00%
Net margin — (16.50%) 0.00%
Free cash flow margin 0.00% (15.66%) 0.00%
Return on equity 0.00% (21.93%) (0.40%)
Return on assets 0.00% (17.78%) (3.32%)
Return on invested capital 0.00% (26.67%) 0.00%

Growth

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (2.74%) 10.01%
EPS growth (last fiscal year) (139.63%) 80.33% —
Revenue growth, 5-year CAGR 44.20% 247.74% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Debt to equity (1.08) 0.00 0.05
Current ratio 0.58 5.46 2.31
Net debt to EBITDA (2.75) 2.20 0.85

Dividend

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Market cap 2.44m 3.25m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack